Concepedia

Publication | Closed Access

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

DOI

258

Citations

30

References

2019

Year

Panagiotis A. Konstantinopoulos, William T. Barry, Michael J. Birrer, Shannon N. Westin, Karen A. Cadoo, Geoffrey I. Shapiro, Erica L. Mayer, Roisin E. O’Cearbhaill, Robert L. Coleman, Bose Kochupurakkal,
The Lancet Oncology

References

YearCitations

Page 1